Dermatology
1 drug is in development for Alopecia.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Alopecia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| eq101 | Equillium, Inc. (EQ) |
About this indication
Alopecia context
Dermatology·MeSH: Alopecia (D000505)
Also known as: Baldness, Hair Losses, Loss, Hair
Narrower concepts tracked separately: Androgenetic Alopecia
Prevalence
200.0 / 100K
Incidence
20.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Alopecia?
BioSniper tracks 1 drug in development for Alopecia across 1 company.
How many clinical trials target Alopecia?
There are 6 clinical trials targeting Alopecia tracked by BioSniper.
What is the prevalence of Alopecia?
The estimated prevalence of Alopecia is approximately 200.0 per 100,000 population.